Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

British Journal of Cancer

Volumn 84, Issue 2, 2001, Pages 157-163

  Jaeckle, K A ^a,b,c,d,e   Phuphanich, S ^a,b,c,d,e   Van den Bent, M J ^a,b,c,d,e   Aiken, R ^a,b,c,d,e   Batchelor, T ^a,b,c,d,e   Campbell, T ^a,b,c,d,e   Fulton, D ^a,b,c,d,e   Gilbert, M ^a,b,c,d,e   Heros, D ^a,b,c,d,e   Rogers, L ^a,b,c,d,e   O'Day, S J ^a,b,c,d,e   Akerley, W ^a,b,c,d,e   Allen, J ^a,b,c,d,e   Baidas, S ^a,b,c,d,e   Gertler, S Z ^a,b,c,d,e   Greenberg, H S ^a,b,c,d,e   LaFollette, S ^a,b,c,d,e   Lesser, G ^a,b,c,d,e   Mason, W ^a,b,c,d,e   Recht, L ^a,b,c,d,e   Wong, E ^a,b,c,d,e   Chamberlain, M C ^a,b,c,d,e   Cohn, A ^a,b,c,d,e   Glantz, M J ^a,b,c,d,e   Gutheil, J C ^a,b,c,d,e   Maria, B ^a,b,c,d,e   Moots, P ^a,b,c,d,e   New, P ^a,b,c,d,e   Russell, C ^a,b,c,d,e   Shapiro, W ^a,b,c,d,e   Swinnen, L ^a,b,c,d,e   Howell, S B ^a,b,c,d,e   more..

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast cancer; Cytarabine; Drug delivery; Neoplastic meningitis

Indexed keywords

CYTARABINE; DEXAMETHASONE;

ADULT; AGED; ARACHNOIDITIS; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ARACHNOIDITIS; BREAST NEOPLASMS; COHORT STUDIES; CYTARABINE; DELAYED-ACTION PREPARATIONS; FEMALE; HEADACHE; HUMANS; INJECTIONS, SPINAL; MENINGEAL NEOPLASMS; MIDDLE AGED; NAUSEA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TREATMENT REFUSAL; VOMITING;

EID: 17744379386     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1574     Document Type: Article

References (22)

1. Leptomeningeal carcinomatosis - Presenting features and prognostic factors
2. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection
3. Meningeal carcinomatosis in breast cancer
4. Prognostic significance of coexistent bulky metastatic central nerous system disease in patients with leptomeningeal metastases
5. Carcinomatous meningitis secondary to breast cancer: Predictors of response to combined modality therapy
6. Meningeal carcinomatosis in patients with breast carcinoma
7. Combination intraventricular chemotherapy for meningeal neoplasia
8. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary?
9. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors
10. The effect of 1-β-D-arabinofuranosyl-cytosine on growth, viability, and DNA synthesis of mouse L-cells
11. Clinical outcome in aggresively treated meningeal carcinomatosis
12. NCCN clinical practice guidelines for carcinomatous/lymphomatous meningitis
13. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis
14. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis
15. Regional chemotherapy
16. Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant
17. Extended CSF cytarabine exposure following intrathecal administration of DTC 101
18. Fate of the predominant phospholipid component of DepoFoam drug delivery matrix after intrathecal administration of sustained-release encapsulated cytarabine in rats
19. Diagnosis and treatment of patients with meningeal carcinomatosis
20. Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma
21. Methotrexate distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections
22. Cytosine arabinoside cerebrospinal fluid kinetics